Focus On Research With Peter Stambrook, PhD
Peter Stambrook, PhD, co-leader of the UC Cancer Institute Comprehensive Head and Neck Center, and Charlotte Auerbach, PhD, the scientist who discovered that mustard gas causes mutations, have something in common.
"Just looking at this list of my predecessors (who have won the Environmental Mutagenesis and Genomics Society Award for outstanding research contributions) is humbling, said Stambrook, looking down at the printed paper in his hand. "These are some pretty important people.
In September, Stambrook received the 2013 EMGS Award for seminal contributions to a number of different research areas, including the molecular bases of DNA replication, the cellular response to DNA damage, genomic instability, mutagenesis and cell death. He is the 41st person to receive the award, which has been given since 1972.
Stambrooks work spans back to his graduate student days at SUNY Buffalo and postdoctoral fellowship at the University of Kentucky Medical Center from 1969 to 1971. From that point, he served in various academic roles and continued his research at the Carnegie Institution of Washington and Case Western Reserve University.
He joined the faculty at the UC College of Medicine in 1980, rising through the ranks to become Francis Brunning Professor and Chairman of what is now called the department of cancer biology. He now serves as a professor in the department of molecular genetics, biochemistry and microbiology.
Throughout the years and with his numerous academic and research contributions, he has published findings that show how cells maintain and preserve their genetic makeup.
"Particularly, weve discovered the mechanisms that embryonic stem cells utilize to help them replicate and preserve their integrity, he says. "Weve discovered how their DNA composition replicates and repairs itself.
Stambrook says he published a paper with Ronald Warnick, MD, John M. Tew, Jr., MD, Chair in Neurosurgical Oncology and professor, which showed how genes from the herpes simplex virus can kill neighboring cells which could be used to create genetic therapies.
"We published that study 20 years ago, and its been cited almost 400 times by other researchers, he says.
Hes also the recipient of a large National Institutes of Health Training Grant for which hes been given renewal funds for over 20 years.
Aside from researching, teaching and participating in organizations such as the Israel Cancer Research Fund, with which hes been involved about 10 years, the UC Board of Trustees and the
American Cancer Society, Ohio Division Board, Stambrookborn in London to parents who were war refugees from Viennasays he a true "football loving Englishman.
"I love soccer, but I dont play it much anymore, he says. "But I still watch it.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.